Key facts
- It has raised $50K; the latest was Seed Round ($50K) in Aug 2025.
- Aesthetics360 has filed 1 Form D with the SEC, most recently Aug 2025 ($50K sold to 1 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Aesthetics360
- ·The full record, as it builds
Funding rounds
No funding rounds for Aesthetics360 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aesthetics360
Developer of an aesthetics intelligence platform designed for personalized patient journeys, revenue drive, and optimized outcomes. The company's platform utilizes artificial intelligence(AI) to help with clinical workflow, automated documentation, AI-based patient education, and consultation, enabling aesthetic medicine practitioners to tailor treatment recommendations based on sentiment analysis and patient preferences while focusing on client retention and sales.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2024
- Employees
- 11
- Website
- aesthetics360.com/
- Ownership
- Privately Held (backing)
Aesthetics360 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aesthetics360 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aesthetics360 in its N-PORT filings yet. We sweep new filings monthly.